Organon Analyst Ratings
Organon Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 104.47% | Piper Sandler | $33 → $32 | Maintains | Overweight |
| 10/11/2023 | 40.58% | Morgan Stanley | $27 → $22 | Maintains | Equal-Weight |
| 09/21/2023 | 78.91% | Barclays | → $28 | Initiates Coverage On | → Overweight |
| 08/09/2023 | 72.52% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 05/08/2023 | 59.74% | Morgan Stanley | $26 → $25 | Maintains | Equal-Weight |
| 03/16/2023 | 110.86% | Raymond James | → $33 | Initiates Coverage On | → Outperform |
| 11/04/2022 | 53.35% | Morgan Stanley | $27 → $24 | Maintains | Equal-Weight |
| 10/14/2022 | 59.74% | B of A Securities | $37 → $25 | Downgrades | Neutral → Underperform |
| 10/12/2022 | 72.52% | Morgan Stanley | $35 → $27 | Maintains | Equal-Weight |
| 09/06/2022 | 117.25% | Piper Sandler | $37 → $34 | Upgrades | Neutral → Overweight |
| 08/05/2022 | 136.42% | B of A Securities | $40 → $37 | Downgrades | Buy → Neutral |
| 07/08/2022 | 117.25% | Morgan Stanley | $35 → $34 | Maintains | Equal-Weight |
| 04/27/2022 | 155.59% | Goldman Sachs | → $40 | Initiates Coverage On | → Buy |
| 04/06/2022 | 123.64% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
| 02/22/2022 | 136.42% | Morgan Stanley | $35 → $37 | Maintains | Equal-Weight |
| 10/07/2021 | 123.64% | Piper Sandler | → $35 | Initiates Coverage On | → Neutral |
| 09/01/2021 | 174.76% | B of A Securities | → $43 | Initiates Coverage On | → Buy |
| 08/16/2021 | 123.64% | Morgan Stanley | $33 → $35 | Maintains | Equal-Weight |
| 07/23/2021 | 123.64% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 07/22/2021 | 123.64% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 06/15/2021 | 142.81% | JP Morgan | → $38 | Initiates Coverage On | → Neutral |
| 06/11/2021 | 110.86% | Morgan Stanley | → $33 | Initiates Coverage On | → Equal-Weight |
| 06/10/2021 | — | Evercore ISI Group | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月25日 | 104.47% | 派珀·桑德勒 | $33→$32 | 維護 | 超重 |
| 2023年10月11日 | 40.58% | 摩根士丹利 | $27→$22 | 維護 | 等重 |
| 2023年09月21日 | 78.91% | 巴克萊 | →$28 | 開始承保 | →超重 |
| 08/09/2023 | 72.52% | 摩根士丹利 | $25→$27 | 維護 | 等重 |
| 05/08/2023 | 59.74% | 摩根士丹利 | $26→$25 | 維護 | 等重 |
| 03/16/2023 | 110.86% | 雷蒙德·詹姆斯 | →$33 | 開始承保 | →跑贏大盤 |
| 11/04/2022 | 53.35% | 摩根士丹利 | $27→$24 | 維護 | 等重 |
| 10/14/2022 | 59.74% | B of A證券 | $37→$25 | 評級下調 | 中性→表現不佳 |
| 10/12/2022 | 72.52% | 摩根士丹利 | $35→$27 | 維護 | 等重 |
| 09/06/2022 | 117.25% | 派珀·桑德勒 | $37→$34 | 升級 | 中性→超重 |
| 08/05/2022 | 136.42% | B of A證券 | $40→$37 | 評級下調 | 購買→中性 |
| 07/08/2022 | 117.25% | 摩根士丹利 | $35→$34 | 維護 | 等重 |
| 04/27/2022 | 155.59% | 高盛 | →$40 | 開始承保 | →購買 |
| 04/06/2022 | 123.64% | 摩根士丹利 | $37→$35 | 維護 | 等重 |
| 02/22/2022 | 136.42% | 摩根士丹利 | $35→$37 | 維護 | 等重 |
| 10/07/2021 | 123.64% | 派珀·桑德勒 | →$35 | 開始承保 | →中性 |
| 09/01/2021 | 174.76% | B of A證券 | →$43 | 開始承保 | →購買 |
| 08/16/2021 | 123.64% | 摩根士丹利 | $33→$35 | 維護 | 等重 |
| 07/23/2021 | 123.64% | 花旗集團 | →$35 | 開始承保 | →購買 |
| 07/22/2021 | 123.64% | 花旗集團 | →$35 | 開始承保 | →購買 |
| 2021/06/15 | 142.81% | 摩根大通 | →$38 | 開始承保 | →中性 |
| 2021/11/06 | 110.86% | 摩根士丹利 | →$33 | 開始承保 | →等重 |
| 2021/10/06 | - | Evercore ISI集團 | 開始承保 | →跑贏大盤 |
What is the target price for Organon (OGN)?
Organon(OGN)的目標價是多少？
The latest price target for Organon (NYSE: OGN) was reported by Piper Sandler on October 25, 2023. The analyst firm set a price target for $32.00 expecting OGN to rise to within 12 months (a possible 104.47% upside). 7 analyst firms have reported ratings in the last year.
Piper Sandler於2023年10月25日報道了Organon(紐約證券交易所代碼：OGN)的最新目標價。這家分析公司將目標價定為32美元，預計OGN將在12個月內上漲至(可能上漲104.47%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Organon (OGN)?
分析師對Organon(OGN)的最新評級是多少？
The latest analyst rating for Organon (NYSE: OGN) was provided by Piper Sandler, and Organon maintained their overweight rating.
分析師對Organon(紐約證券交易所代碼：OGN)的最新評級由Piper Sandler提供，Organon維持其增持評級。
When is the next analyst rating going to be posted or updated for Organon (OGN)?
Organon(OGN)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organon was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Organon的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Organon的上一次評級是在2023年10月25日提交的，因此您應該預計下一次評級將在2024年10月25日左右提供。
Is the Analyst Rating Organon (OGN) correct?
分析師評級機構(OGN)正確嗎？
While ratings are subjective and will change, the latest Organon (OGN) rating was a maintained with a price target of $33.00 to $32.00. The current price Organon (OGN) is trading at is $15.65, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Organon(OGN)評級維持不變，目標價在33.00美元至32.00美元之間。Organon(OGN)目前的交易價格為15.65美元，超出了分析師的預測區間。